Atrial fibrillation in amyloidotic cardiomyopathy: prevalence, incidence, risk factors and prognostic role
- 21 May 2015
- journal article
- Published by Informa UK Limited in Amyloid
- Vol. 22 (3), 147-155
- https://doi.org/10.3109/13506129.2015.1028616
Abstract
Although atrial fibrillation (AF) is a known complication of amyloidotic cardiomyopathy (AC), a precise pathophysiological and prognostic characterization is not available. We therefore aimed to assess prevalence, incidence, risk factors and prognostic significance of AF in light-chain (AL), hereditary transthyretin-related (m-ATTR) and non-mutant transthyretin-related (wt-ATTR) AC.Retrospective study of 262 patients with AC (123 AL, 94 m-ATTR, 45 wt-ATTR) from a single center.AF prevalence was 15% (AL 9%, m-ATTR 11%, wt-ATTR 40%). During a median follow-up of 1.2 years 11 patients developed AF (2.1% person-years). Age, heart failure (HF), left ventricular (LV) ejection fraction, renal involvement, left atrial size and right atrial pressure were independently associated with AF. AF was associated with incident HF but not with increased mortality. All AF patients were prescribed warfarin and none suffered thromboembolic events.In AC the prevalence of AF varies widely according to etiology with a mean value of 15% that reaches 40% in wt-ATTR amyloidosis. Age, HF, LV ejection fraction, left atrial size and right atrial pressure were the main independent risk factors, while wall thickness and etiology were not the main independent risk factors. AF does not seem to impact all-cause mortality but was strongly associated with prevalent and incident HF.Keywords
This publication has 34 references indexed in Scilit:
- Novel Drugs Targeting Transthyretin AmyloidosisCurrent Heart Failure Reports, 2014
- Diastolic Dysfunction and Risk of Atrial FibrillationCirculation, 2012
- Transthyretin-related amyloidoses and the heart: a clinical overviewNature Reviews Cardiology, 2010
- Amyloid Heart DiseaseProgress in Cardiovascular Diseases, 2010
- Biochemical characterisation of amyloid by endomyocardial biopsyAmyloid, 2009
- Diagnosis and Management of the Cardiac AmyloidosesCell Metabolism, 2005
- Misdiagnosis of Hereditary Amyloidosis as AL (Primary) AmyloidosisNew England Journal of Medicine, 2002
- Amyloidosis: Recognition, Confirmation, Prognosis, and TherapyMayo Clinic Proceedings, 1999
- A review of the amyloidoses that infiltrate the heartClinical Cardiology, 1998
- The Systemic AmyloidosesNew England Journal of Medicine, 1997